Megafine Pharma plans expansion at Vapi unit

Megafine Pharma is planning to expand its manufacturing capacity in GIDC Vapi in Valsad district of Gujarat. The project involves expanding manufacturing capacity to produce drug intermediates like Disodium Pamoate (DSP), Thiophene?2? Aldehyde (T2A), Ammonium Benzene Sulphonate (ABS), 3?Piperazin?1?yl?1,2?benzisothiazole (PBT FB), 4,6?Dichloro?2?(propylthio)pyrimidin?5?amine (GTR?3), Prasugrel Free Base etc., The project cost is estimated at Rs. 88.5 million

Company Profile : Megafine Pharma Pvt Ltd